Compare CMP & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMP | ATRC |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2003 | 2005 |
| Metric | CMP | ATRC |
|---|---|---|
| Price | $29.95 | $31.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $21.50 | ★ $51.17 |
| AVG Volume (30 Days) | 501.2K | ★ 1.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.73 | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $1.29 | $12.21 |
| P/E Ratio | $41.03 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $16.40 | $25.36 |
| 52 Week High | $34.50 | $43.18 |
| Indicator | CMP | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 64.81 |
| Support Level | $27.74 | $30.77 |
| Resistance Level | $32.43 | $32.56 |
| Average True Range (ATR) | 1.45 | 1.44 |
| MACD | -0.06 | 0.31 |
| Stochastic Oscillator | 48.31 | 99.40 |
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.